143 related articles for article (PubMed ID: 29766448)
1. Cross-sectional study on hospitalizations related to herpes zoster in an Italian region, 2008-2016.
Cocchio S; Baldovin T; Furlan P; Bertoncello C; Buja A; Saia M; Fonzo M; Baldo V
Aging Clin Exp Res; 2019 Jan; 31(1):145-150. PubMed ID: 29766448
[TBL] [Abstract][Full Text] [Related]
2. Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia.
Friesen KJ; Chateau D; Falk J; Alessi-Severini S; Bugden S
BMC Infect Dis; 2017 Jan; 17(1):69. PubMed ID: 28086817
[TBL] [Abstract][Full Text] [Related]
3. Epidemiology and economic burden of herpes zoster and post-herpetic neuralgia in Italy: a retrospective, population-based study.
Gialloreti LE; Merito M; Pezzotti P; Naldi L; Gatti A; Beillat M; Serradell L; di Marzo R; Volpi A
BMC Infect Dis; 2010 Aug; 10():230. PubMed ID: 20682044
[TBL] [Abstract][Full Text] [Related]
4. Burden of herpes zoster and postherpetic neuralgia in Japanese adults 60 years of age or older: Results from an observational, prospective, physician practice-based cohort study.
Sato K; Adachi K; Nakamura H; Asano K; Watanabe A; Adachi R; Kiuchi M; Kobayashi K; Matsuki T; Kaise T; Gopala K; Holl K
J Dermatol; 2017 Apr; 44(4):414-422. PubMed ID: 27917531
[TBL] [Abstract][Full Text] [Related]
5. [Burden of herpes zoster and postherpetic neuralgia: Incidence, proportion, and associated costs in the French population aged 50 or over].
Mick G; Gallais JL; Simon F; Pinchinat S; Bloch K; Beillat M; Serradell L; Derrough T
Rev Epidemiol Sante Publique; 2010 Dec; 58(6):393-401. PubMed ID: 21094001
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Pellissier JM; Brisson M; Levin MJ
Vaccine; 2007 Nov; 25(49):8326-37. PubMed ID: 17980938
[TBL] [Abstract][Full Text] [Related]
7. Herpes zoster and postherpetic neuralgia in Catalonia (Spain).
Salleras L; Salleras M; Salvador P; Soldevila N; Prat A; Garrido P; Domínguez A
Hum Vaccin Immunother; 2015; 11(1):178-84. PubMed ID: 25483532
[TBL] [Abstract][Full Text] [Related]
8. Temporal trends in herpes zoster-related hospitalizations in Italy, 2001-2013: differences between regions that have or have not implemented varicella vaccination.
Valente N; Cocchio S; Stefanati A; Baldovin T; Martinelli D; Prato R; Baldo V; Gabutti G
Aging Clin Exp Res; 2017 Aug; 29(4):771-779. PubMed ID: 28608255
[TBL] [Abstract][Full Text] [Related]
9. Incidence of herpes zoster and post-herpetic neuralgia in Italy: Results from a 3-years population-based study.
Alicino C; Trucchi C; Paganino C; Barberis I; Boccalini S; Martinelli D; Pellizzari B; Bechini A; Orsi A; Bonanni P; Prato R; Iannazzo S; Icardi G
Hum Vaccin Immunother; 2017 Feb; 13(2):399-404. PubMed ID: 27925843
[TBL] [Abstract][Full Text] [Related]
10. A retrospective survey on herpes zoster disease burden and characteristics in Beijing, China.
Lu L; Suo L; Li J; Pang X
Hum Vaccin Immunother; 2018; 14(11):2632-2635. PubMed ID: 30059639
[TBL] [Abstract][Full Text] [Related]
11. The burden of disease of Herpes Zoster in Tuscany.
Levi M; Bellini I; Capecchi L; Pieri L; Bechini A; Boccalini S; Callaioli S; Gasparini R; Panatto D; Tiscione E; Bonanni P
Hum Vaccin Immunother; 2015; 11(1):185-91. PubMed ID: 25483534
[TBL] [Abstract][Full Text] [Related]
12. Herpes zoster related healthcare burden and costs in immunocompromised (IC) and IC-free populations in England: an observational retrospective database analysis.
Curran D; Hunjan M; El Ghachi A; El-Hahi Y; Bianco V; Ferreira G
BMJ Open; 2019 Aug; 9(8):e023502. PubMed ID: 31462457
[TBL] [Abstract][Full Text] [Related]
13. Burden of herpes zoster: the direct and comorbidity costs of herpes zoster events in hospitalized patients over 50 years in France.
Blein C; Gavazzi G; Paccalin M; Baptiste C; Berrut G; Vainchtock A
BMC Infect Dis; 2015 Aug; 15():350. PubMed ID: 26286598
[TBL] [Abstract][Full Text] [Related]
14. Burden of disease from shingles and post-herpetic neuralgia in the over 80 year olds in the UK.
Matthews I; Duong M; Parsons VL; Nozad B; Qizilbash N; Patel Y; Guimicheva B
PLoS One; 2020; 15(2):e0229224. PubMed ID: 32097441
[TBL] [Abstract][Full Text] [Related]
15. Economic Burden of Herpes Zoster ("culebrilla") in Latin America.
Rampakakis E; Pollock C; Vujacich C; Toniolo Neto J; Ortiz Covarrubias A; Monsanto H; Johnson KD
Int J Infect Dis; 2017 May; 58():22-26. PubMed ID: 28267595
[TBL] [Abstract][Full Text] [Related]
16. Burden of herpes zoster requiring hospitalization in Spain during a seven-year period (1998-2004).
Gil A; Gil R; Alvaro A; San Martín M; González A
BMC Infect Dis; 2009 May; 9():55. PubMed ID: 19422687
[TBL] [Abstract][Full Text] [Related]
17. Incidence of herpes zoster and its complications in Germany, 2005-2009.
Hillebrand K; Bricout H; Schulze-Rath R; Schink T; Garbe E
J Infect; 2015 Feb; 70(2):178-86. PubMed ID: 25230396
[TBL] [Abstract][Full Text] [Related]
18. [Herpes Zoster and its prevention in Italy. Scientific consensus statement].
Franco E; Gabutti G; Bonanni P; Conversano M; Stefano Valente ME; Ferro A; Icardi G; Antonio Volpi ML; Maggi S; Rossi A; Scotti S; Vitale F; Greco D;
Ig Sanita Pubbl; 2014; 70(1):111-27. PubMed ID: 24770367
[TBL] [Abstract][Full Text] [Related]
19. A population-based study of the incidence and complication rates of herpes zoster before zoster vaccine introduction.
Yawn BP; Saddier P; Wollan PC; St Sauver JL; Kurland MJ; Sy LS
Mayo Clin Proc; 2007 Nov; 82(11):1341-9. PubMed ID: 17976353
[TBL] [Abstract][Full Text] [Related]
20. Analysis of real-world health care costs among immunocompetent patients aged 50 years or older with herpes zoster in the United States.
Meyers JL; Madhwani S; Rausch D; Candrilli SD; Krishnarajah G; Yan S
Hum Vaccin Immunother; 2017 Aug; 13(8):1861-1872. PubMed ID: 28605285
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
